All In MedTech

Device Trial Radar · NCT01372462

Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease

A Pilot Study of the Physiologic Effects of Using the Breathe Technologies Noninvasive Open Ventilation System During Constant Work Rate Exercise in Subjects With Chronic Obstructive Pulmonary Disease

Last checked: Nov 20, 2026Latest source record: Oct 12, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

15

Actual

Start

Jul 2011

Primary completion

May 2012

Study completion May 2012

Sponsor

Lead sponsor
Breathe Technologies, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 14, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Male only, from 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Pilot study in 15 stable male subjects with severe-to-very severe Chronic Obstructive Pulmonary Disease (COPD) to evaluate the effects of short term use of the Breathe Technologies noninvasive open ventilation (NIOV) system on respiratory mechanics during constant work rate exercise in subjects with severe COPD.

Conditions

  • Chronic Obstructive Pulmonary Disease

Interventions

  • NIOV - Room AirDevice

    Noninvasive ventilation with device powered by compressed room air.

  • NIOV - OxygenDevice

    Noninvasive ventilation with device powered by compressed medical (100%) oxygen.

  • Nasal Cannula OxygenDevice

    Supplemental oxygen delivered using a standard nasal cannula connected to 100% medical oxygen.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Exercise Duration for Constant Work Rate Exercise Tests Under 4 Test ConditionsTime frame: Study days 1,2,3, and 4; Day 1 for no treatment; day 2 for no treatment and NIOV - Room Air and NIOV - oxygen; Day 3 for no treatment and NIOV - Room Air and NIOV - oxygen; Day 4 for NIOV - oxygen and Nasal Cannula Oxygen.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Harbor-UCLA Medical Center

    Torrance, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.